跳至主要内容
临床试验/IRCT20131125015536N15
IRCT20131125015536N15尚未招募2 期

Investigating the effects of MCT-modified ketogenic diet on clinical symptoms, systemic inflammation and the expression of gene coding B-catenin in patients with endometriosis: A parallel randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 35 years(—)
性别
Female

入选标准

  • Age range between 25 and 35 years
  • being married
  • Diagnosis of endometriosis based on laparoscopic and pathological findings
  • Having stage one or two endometriosis based on diagnostic laparoscopy or patients with a higher grade who underwent diagnostic-therapeutic laparoscopy and 3 months after laparoscopy, their disease stage was reduced to stage one or two
  • Body mass index between 21 and 25 kg/m2
  • Having a VAS score of 3 out of 10 or greater than 3 out of 10 for pelvic pain and dyspareunia (pain during intercourse) and dyschezia (pain during defecation)

排除标准

  • Smoking and alcohol consumption
  • Taking antidepressants for the past 6 months
  • Pregnancy, breastfeeding and menopause
  • Women who intend to become pregnant or take drugs such as clomifene, letrozole and gonadotropin
  • Intestinal malabsorption (history of bariatric surgery, inflammatory bowel disease, celiac disease)
  • Suffering from other diseases such as kidney disease and kidney stones, liver disorders and gallstones, cancer, heart diseases, acute and chronic infectious diseases, type 1 and 2 diabetes, Cushing's disease, acromegaly, and gigantism.
  • Having myoma or polyps in the uterus

研究者

相似试验